• Guideline-led prescribing to heart failure patients in Ireland and Egypt 

  El Hadidi, Seif (University College Cork, 2019-06)

  Introduction: Guidelines strongly recommend patients with Heart Failure (HF) be treated with multiple medications proven to improve clinical outcomes, as tolerated. Guideline-led prescribing of HF evidence-based medicines ...
• Heart failure prescribing quality at discharge from a critical care unit in Egypt: The impact of multidisciplinary care 

  El Hadidi, Seif; Samir Bazan, Naglaa; Byrne, Stephen; Darweesh, Ebtissam; Bermingham, Margaret (MDPI, 2020-09-01)

  Discharge prescriptions for heart failure (HF) patients may not adhere to the clinical practice guidelines. This study aimed to assess the impact of the clinical pharmacist as a member of a multidisciplinary team on the ...
• Guideline-led prescribing to ambulatory heart failure patients in a cardiology outpatient service 

  El Hadidi, Seif; Vaughan, Carl; Kerins, David; Byrne, Stephen; Darweesh, Ebtissam; Bermingham, Margaret (Springer, 2021-01-07)

  Background Guidelines recommend heart failure (HF) patients be treated with multiple medications at doses proven to improve clinical outcomes. Objective To study guideline-led prescribing in an Irish outpatient HF population. ...
• Stakeholders’ knowledge, attitudes and practices to pharmacovigilance and adverse drug reaction reporting in clinical trials: a mixed methods study 

  O'Riordan, David; Kinane, Mary; Walsh, Kieran A.; Shiely, Frances; Eustace, Joe; Bermingham, Margaret (Springer, 2020-06-07)

  Purpose: The purpose of this study was to explore the knowledge, attitudes and practices of health professionals working in clinical trials, to pharmacovigilance and adverse drug reaction (ADR) reporting. Methods: A mixed ...
• Advances in the design of (nano)formulations for delivery of antisense oligonucleotides and small interfering RNA: Focus on the central nervous system 

  Mendonça, Monique C. P.; Kont, Ayse; Aburto, Maria Rodriguez; Cryan, John F.; O'Driscoll, Caitriona M. (American Chemical Society, 2021-03-18)

  RNA-based therapeutics have emerged as one of the most powerful therapeutic options used for the modulation of gene/protein expression and gene editing with the potential to treat neurodegenerative diseases. However, the ...

View more